Fungal Infections Associated With the Use of Novel Immunotherapeutic Agents.

Published in: Current clinical microbiology reports (2020)

Treatment-related toxicities that require prolonged immunosuppressive agents appear to play a key role in the development of fungal infections during immunotherapy. Ongoing surveillance is needed to fully address the risks of fungal infections with these novel agents.

Keyphrases

cell wall
climate change